BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18006910)

  • 1. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.
    Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.
    Kemppainen KJ; Tammela TL; Auvinen A; Murtola TJ
    Cancer Causes Control; 2011 Oct; 22(10):1445-52. PubMed ID: 21769492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.
    Bañez LL; Klink JC; Jayachandran J; Lark AL; Gerber L; Hamilton RJ; Masko EM; Vollmer RT; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):722-8. PubMed ID: 20160265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
    Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
    Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term statin use and the risk of gallstone disease: A population-based case-control study.
    Erichsen R; Frøslev T; Lash TL; Pedersen L; Sørensen HT
    Am J Epidemiol; 2011 Jan; 173(2):162-70. PubMed ID: 21084557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Height, urban-born and prostate cancer risk in Japanese men.
    Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M
    Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins increase the risk of prostate cancer: a population-based case-control study.
    Chang CC; Ho SC; Chiu HF; Yang CY
    Prostate; 2011 Dec; 71(16):1818-24. PubMed ID: 21480313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.
    Murtola TJ; Tammela TL; Määttänen L; Hakama M; Auvinen A
    Eur J Cancer; 2007 Mar; 43(4):775-81. PubMed ID: 17251005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
    Jacobs EJ; Rodriguez C; Brady KA; Connell CJ; Thun MJ; Calle EE
    J Natl Cancer Inst; 2006 Jan; 98(1):69-72. PubMed ID: 16391373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasectomy and prostate cancer.
    Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
    J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States.
    Colli JL; Amling CL
    Urol Oncol; 2009; 27(2):170-3. PubMed ID: 18367120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of cancer in users of statins.
    Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
    J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
    Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.